|1.||Holme, Ingar: 1 article (01/2011)|
|2.||Tønnesen, Philip: 1 article (01/2011)|
|3.||Tonstad, Serena: 1 article (01/2011)|
|4.||Shrikhande, A: 1 article (05/2010)|
|5.||Mather, R J: 1 article (05/2010)|
|6.||Ward, K M: 1 article (05/2010)|
|7.||Cremers, T: 1 article (05/2010)|
|8.||Coe, J W: 1 article (05/2010)|
|9.||Tingley, F D: 1 article (05/2010)|
|10.||Hurst, R S: 1 article (05/2010)|
|1.||Tobacco Use Disorder (Nicotine Dependence)
07/01/2003 - "The present results confirm important role for alpha4beta2 nAChRs in mediating nicotine dependence and suggest that SSR591813, a partial agonist at this particular nAChR subtype, may have therapeutic potential in the clinical management of smoking cessation."
07/01/2003 - "SSR591813 shows activity in animal models of nicotine dependence at doses devoid of unwanted side effects typically observed with nicotine (hypothermia and cardiovascular effects). "
05/01/2010 - "Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence."
|2.||Substance Withdrawal Syndrome (Withdrawal Symptoms)
|2.||nicotinic receptor alpha4beta2